España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sorrento Therapeutics Inc
SRNEQ
OTC
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.010000
-0.02
-66.67%
Pre-Market: Apr 3, 4:07 PM EDT
Get Report
Comment
Sorrento Therapeutics Inc (SRNEQ) Forecast
News
Earnings
Sorrento Therapeutics Inc (SRNEQ) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sorrento Therapeutics Inc (OTC:SRNEQ) Stock
Sorrento Therapeutics Inc Stock (OTC: SRNEQ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 26, 2024
Scilex Holding Company Announces That The U.S...
Benzinga Newsdesk
Monday, March 04, 2024
Reported Earlier, Scilex Announces Move To Ex...
Benzinga Newsdesk
Tuesday, February 27, 2024
Virpax Pharmaceuticals Announces Proposed Set...
Benzinga Newsdesk
Tuesday, October 03, 2023
Scilex Holding Company Provides Notice To All...
Benzinga Newsdesk
Thursday, September 21, 2023
Scilex Assumed $100M In Debt Owed To Oramed P...
Benzinga Newsdesk
Scilex Holding Company Announces The Consumma...
Benzinga Newsdesk
Tuesday, August 08, 2023
Sorrento Therapeutics, Inc. Announces Auction For Sale Of Scilex Securities And Bankruptcy Court Approval Of Stalking Horse Bid
Happy Mohamed
Friday, July 21, 2023
Sorrento Announces Launch Of Voluntary Offering To Dividend Short Holders With Deadline To Participate By July 27, 2023
Happy Mohamed
Thursday, July 20, 2023
Sorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering Of Restricted Common Stock Of Scilex Holding Company For Dividend Short Holders
Happy Mohamed
Thursday, June 15, 2023
Scilex Holding Company Announces That Sorrent...
Benzinga Newsdesk
Thursday, June 01, 2023
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended May 2023, And Year-To-Date May 2023, Based On Currently Available Information; May 23 Net Sales $4.2M-$5.1M
Happy Mohamed
Wednesday, May 31, 2023
Scilex Holding Company Enters Master Distributor Agreement Among CH Trading Group LLC And Farouk, Maamoun Tamer & Co. For the Distribution of ZTlido in the Kingdom of Saudi Arabia
Happy Mohamed
Monday, May 22, 2023
Scilex Holding Company Added To The Prelimina...
Benzinga Newsdesk
Sunday, May 14, 2023
Sorrento Therapeutics Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts
Charles Gross
Thursday, May 04, 2023
Scilex Holding Company Announces Complete Enrollment Of A Phase 2 Study To Evaluate The Safety And Efficacy of SP-103 5.4%, Triple Strength Formulation Of ZTlido, For The Treatment Of Acute Low Back Pain
Happy Mohamed
Wednesday, April 26, 2023
Scilex Holding Co Announces That Its Majority Stockholder, Sorrento Therapeutics, Inc., Has Issued A Notice That Sorrento's Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Stock Distributed By Sorrento To Its Stockholders As A Dividend
Happy Mohamed
Monday, April 17, 2023
Scilex Inks Distribution Agreement For Neuropathic Painkiller ZTlido In The Middle East And North Africa
Akanksha Bakshi
Scilex Holding Company Enters Into Master Distributor Agreement With CH Trading Group LLC And AD Ports Group For The Distribution Of ZTlido In The Middle East And North Africa Region
Happy Mohamed
Wednesday, March 08, 2023
Scilex Holding Company And CH Trading Group Announce Territory Distribution Agreement To Expand Commercialization Of ZTlido For The Middle East And North Africa With $105M Minimum Multi-Year Purchase Commitment
Happy Mohamed
Monday, February 27, 2023
Scilex Holding Company Announces The Commercial Launch Of ELYXYBTM In The U.S., Strengthening Its Leadership Position In Non-Opioid Pain Management
Happy Mohamed
